The Washington PostDemocracy Dies in Darkness

‘Triple whammy’ of good news catapults Dow more than 900 points

Investors seize on a promising vaccine trial, stimulus hints from the Fed and more states kickstarting their economies to lift stocks across-the-board

The Wall Street sign is pictured at the New York Stock Exchange in Manhattan. (Carlo Allegri/Reuters)

A “triple whammy” of good news — led by promising results from a coronavirus vaccine trial — buoyed investors Monday, powering Wall Street to strong across-the-board gains.

The Dow Jones industrial average surged nearly 700 points at the opening bell, then kept going, after Moderna announced that an early-stage human trial for its coronavirus vaccine successfully produced covid-19 antibodies in participants. The biotech company said a large clinical trial to determine the treatment’s effectiveness would follow in July. Moderna’s shares soared more than 19 percent.

Investors also found comfort in comments made by Federal Reserve Chair Jerome H. Powell during a “60 Minutes” interview on CBS broadcast Sunday. He said the central bank is “not out of ammunition by a long shot” in its economic arsenal, even while he cautioned that recovery could stretch late into 2021. The comment came as most states have begun to ease restrictions on businesses and social activity after weeks of stay-at-home orders affecting some 315 million Americans.

The blue chip index’s lead swelled to 911 points, or 3.9 percent, to close at 24,597.37. The broader Standard & Poor’s 500 index soared 3.2 percent to 2,953.91, while the tech-heavy Nasdaq composite advanced 2.4 percent to 9,234.83.

David Rosenberg, chief economist of Rosenberg Research, said investors were being rewarded with a “triple whammy of good news” after two weeks of market volatility marked by dramatic, intraday swings as bad news piled up, interspersed by notes of optimism on the medical research front and rumblings from business.

“For one, there is palpable relief that the majority of the states are reopening their economies, including 75 percent of California,” Rosenberg said in an email to The Post. “Second, there is growing hope that a vaccine is coming our way sooner, rather than later. Lastly, Fed Chairman Jay Powell told investors over the weekend that the central bank’s checkbook remains wide open, strongly hinting that more monetary policy stimulus is on its way.”

The Trump administration’s senior economic adviser seconded that optimism in an interview Monday. “I think that definitely you’re looking at a very strong third quarter, a very strong fourth quarter and probably a great next year,” White House senior economic adviser Kevin Hassett said on CNBC’s “Squawk Box”

“I think the question is not really, ‘When does the recovery start?’ because, absent a second wave of the disease, it’s kind of already begun,” he said.

Most states have started relaxing stay-at-home public health orders. But disease experts caution that reopening too quickly could invite another wave of covid-19 cases. Infections in Texas, Alabama and North Dakota, three of the earliest states to reopen, have spiked in recent days, though that could be a byproduct of increased testing capacity.

Moderna’s coronavirus vaccine shows encouraging early results in human safety trial

Last week, fresh economic data revealed the pandemic’s mounting economic toll: The U.S. Labor Department on Thursday reported weekly jobless claims of 3 million, bringing the two-month total to more than 36 million unemployed. April retail sales plummeted 16.4 percent, a drop that was worse than analysts had predicted as lockdowns kept consumers homebound.

The darkening retail picture prompted some economists to issue even graver predictions for second quarter gross domestic product, given that consumer spending accounts for 70 percent of U.S. economic growth. The economy shrank 4.8 percent in the first quarter — the biggest decline since the Great Recession — and some analysts believe the April to June period could see a contraction as high as 40 percent.

“The economic collapse has taken a dangerous turn where now it is consumer prices that are being pulled down into the abyss as consumers sitting at home have postponed their purchases,” Chris Rupkey, chief financial economist and MUFG Union Bank wrote in commentary. “The danger is that consumers will see that prices are falling and actually stop buying goods and services to wait for even cheaper prices and a better deal which will only serve to prolong the recession and reinforce the economy’s downward spiral into the unknown.”

That put investors in a selling frame of mind, with the Dow ending the week 2.6 percent lower. The S&P 500 fell 2.2 percent and the Nasdaq shed 1.2 percent over the five-day run.

But Monday’s good news saw investors leave safe havens for riskier ground. The yield on the 10-year U.S. Treasury note ticked upward to 0.665 percent in early trading. Bond yields rise as prices drop.

Crude prices continue to recover, adding to the positive sentiment, as the easing of restrictions around the world also reined in fears of an oil glut. West Texas intermediate crude, the U.S. oil benchmark, jumped 7.8 percent to $31.83 a barrel. Brent crude, the global oil benchmark, was trading up 7.7 percent at $35 per barrel.

“The supply cuts of the last month combined with gradual reopening of various countries around the world has put a significant dent in the supply/demand imbalance and alleviated capacity concerns that led to last months panic,” Craig Erlam, an analyst with OANDA, wrote in commentary Monday.

Watch more:

Researchers believe testing for covid-19 antibodies in plasma can lead to possible treatments for the virus and help indicate when to reopen society. (Video: John Farrell, Jonathan Baran/The Washington Post)

Coronavirus: What you need to know

Vaccines: The CDC recommends that everyone age 5 and older get an updated covid booster shot designed to target both the original virus and the omicron variant. Here’s some guidance on when you should get the omicron booster and how vaccine efficacy could be affected by your prior infections.

Variants: Instead of a single new Greek letter variant, a group of immune-evading omicron spinoffs are popping up all over the world. Any dominant variant will likely knock out monoclonal antibodies, targeted drugs that can be used as a treatment or to protect immunocompromised people.

Tripledemic: Hospitals are overwhelmed by a combination of respiratory illnesses, staffing shortages and nursing home closures. And experts believe the problem will deteriorate further in coming months. Here’s how to tell the difference between RSV, the flu and covid-19.

Guidance: CDC guidelines have been confusing — if you get covid, here’s how to tell when you’re no longer contagious. We’ve also created a guide to help you decide when to keep wearing face coverings.

Where do things stand? See the latest coronavirus numbers in the U.S. and across the world. In the U.S., pandemic trends have shifted and now White people are more likely to die from covid than Black people. Nearly nine out of 10 covid deaths are people over the age 65.

For the latest news, sign up for our free newsletter.